Lupin:

• Today's market cap is Rs.38700 Crores Vs Rs.550 Crores  a decade ago : 70 times jump in value.
• Established in 1968.
• Restructured its businesses in CY 2000.
• In CY 2000, got approval of US FDA for its Antibiotic Cefotaxime. Started supply to alliance partners in US.
• Took risk in tapping the regulated markets like US.
• Today, it is 4th largest pharma company in India with 12 manufacturing plants, of which 5 are approved by US FDA.
• 72% revenue from overseas market.
• Global generic market to touch US$ 400 billion by CY 2016 from current level of US$242 billion.
• Taking risk is crucial for a company to grow. Being at the right place at right time is what matters for success.